BPC-157 Supports Vascular and Neurological Repair One underappreciated hallmark of long COVID is endothelial dysfunction damage to the lining of blood vessels that impairs circulation, oxygenation, and tissue delivery.7 BPC-157 has demonstrated angiogenic (new blood vessel formation) effects in research models, upregulating VEGFR2 and promoting collateral circulation in ischemic tissue.8 This matters for two reasons: Cardiovascular symptoms (breathlessness, reduced exercise tolerance, tachycardia) may partly reflect impaired tissue oxygenation from vascular damage Neurological symptoms (brain fog, cognitive impairment) may similarly reflect reduced cerebral blood flow BPC-157's neuroprotective effects shown across models of traumatic brain injury, dopamine dysregulation, and serotonin syndrome also suggest value in supporting the neurotransmitter disruption many long COVID patients experience.9 BPC-157 Modulates Inflammation Without Immune Suppression This is critical
The role of the BBB is to create a tight seal that prevents foreign objects from entering the brain through the bloodstream, said Zoba
Instead, BPC-157 appears to upgrade minor vessels to assume the functions of blocked major vessels
doi:10.3390/ijms19071987 5
The VWD example highlights a broader opportunity across hematology: using healthcare data not only to evaluate treatments but also to improve diagnosis, disease management, and patient outcomes
